![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Aurorium Llc Zeeland Us, based in U.S.A, is a pharmaceutical company.
One of their significant offerings is Cetylpyridinium Chloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2001-265 - Rev 04
This Chemical Type CEP, issued on January 23, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 379 associated with this CEP further emphasizes